RealFeedApp Guinea-Bissau refuses Danish-led vaccine study
Government officials in Guinea-Bissau formally rejected a clinical trial funded by the US and led by Danish researchers investigating alleged nonspecific harms from the hepatitis B newborn dose. Police raided Bandim Health offices and seized vaccines following the decision to cancel the study.
- Field
- medicine and diagnostics
- What they did
- Researchers from Denmark and the US planned to conduct a clinical trial of the hepatitis B vaccine on newborns in Guinea-Bissau to check for alleged nonspecific side effects, but the country's government officially rejected the study.
- Why it matters
- The vaccine has been used safely and effectively globally for decades, so conducting additional trials raises questions among local authorities.
#vaccine#clinical trial#hepatitis b#guinea-bissau#public health
